BCV
DXCM icon

Banque Cantonale Vaudoise’s DexCom DXCM Stock Holding History

Banque Cantonale Vaudoise’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
37,250
+7,170
+24% +$478K 0.35% 53
2026
Q1 		$1.89M Buy
30,080
+23,216
+338% +$1.62M 0.07% 257
2025
Q4 		$456K Buy
6,864
+93
+1% +$6.01K 0.02% 464
2025
Q3 		$456K Sell
6,771
-6,261
-48% -$495K 0.02% 454
2025
Q2 		$1.14M Buy
13,032
+1,346
+12% +$106K 0.05% 335
2025
Q1 		$798K Buy
+11,686
New +$954K 0.04% 392
2024
Q3 		$791K Buy
11,811
+7,433
+170% +$610K 0.03% 350
2024
Q2 		$495K Buy
4,378
+2,427
+124% +$307K 0.02% 440
2024
Q1 		$270K Sell
1,951
-2,887
-60% -$363K 0.01% 522
2023
Q4 		$601K Sell
4,838
-6,362
-57% -$650K 0.03% 420
2023
Q3 		$1.04M Buy
11,200
+2,447
+28% +$276K 0.05% 309
2023
Q2 		$1.12M Sell
8,753
-457
-5% -$55.3K 0.05% 310
2023
Q1 		$1.07M Sell
9,210
-1,929
-17% -$216K 0.05% 293
2022
Q4 		$1.26M Buy
11,139
+3,009
+37% +$330K 0.07% 250
2022
Q3 		$655K Sell
8,130
-106
-1% -$8.98K 0.04% 432
2022
Q2 		$613K Sell
8,236
-3,400
-29% -$310K 0.03% 448
2022
Q1 		$1.49M Sell
11,636
-8,908
-43% -$974K 0.06% 302
2021
Q4 		$2.76M Buy
20,544
+12,236
+147% +$1.76M 0.11% 181
2021
Q3 		$1.14M Sell
8,308
-892
-10% -$112K 0.05% 388
2021
Q2 		$982K Buy
9,200
+800
+10% +$76.8K 0.04% 432
2021
Q1 		$755K Buy
8,400
+800
+11% +$75.1K 0.04% 443
2020
Q4 		$703K Sell
7,600
-3,200
-30% -$286K 0.04% 401
2020
Q3 		$1.11M Sell
10,800
-12,800
-54% -$1.34M 0.07% 245
2020
Q2 		$2.39M Sell
23,600
-19,200
-45% -$1.72M 0.17% 121
2020
Q1 		$2.88M Buy
42,800
+16,800
+65% +$1.05M 0.24% 85
2019
Q4 		$1.42M Buy
+26,000
New +$1.23M 0.1% 233

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Banque Cantonale Vaudoise's DXCM Position: Q2 2026 in Review

Banque Cantonale Vaudoise increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $478K and bringing the position to 37,250 shares worth $2.51M. The position accounts for 0.35% of the portfolio, ranked #53.

Banque Cantonale Vaudoise first reported a position in DXCM in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.88M in Q1 2020. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Banque Cantonale Vaudoise held 37,250 shares of DexCom worth $2.51M as of Q2 2026.
  • Banque Cantonale Vaudoise bought 7,170 DexCom shares in Q2 2026, an estimated $478K.
  • DexCom made up 0.35% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #53 holding.
  • Banque Cantonale Vaudoise first reported a position in DexCom in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's DexCom position peaked at $2.88M in Q1 2020.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.